Literature DB >> 29146106

The hydrophobic trap-the Achilles heel of RND efflux pumps.

Zachary Aron1, Timothy J Opperman2.   

Abstract

Resistance-nodulation-division (RND) superfamily efflux pumps play a major role in multidrug resistance (MDR) of Gram-negative pathogens by extruding diverse classes of antibiotics from the cell. There has been considerable interest in developing efflux pump inhibitors (EPIs) of RND pumps as adjunctive therapies. The primary challenge in EPI discovery has been the highly hydrophobic, poly-specific substrate binding site of the target. Recent findings have identified the hydrophobic trap, a narrow phenylalanine-lined groove in the substrate-binding site, as the "Achilles heel" of the RND efflux pumps. In this review, we will examine the hydrophobic trap as an EPI target and two chemically distinct series of EPIs that bind there.
Copyright © 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adjunctive therapy; Efflux pump; Efflux pump inhibitor; Hydrophobic trap; RND superfamily

Mesh:

Substances:

Year:  2017        PMID: 29146106      PMCID: PMC5949246          DOI: 10.1016/j.resmic.2017.11.001

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  52 in total

1.  MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization.

Authors:  Kiyoshi Nakayama; Yohei Ishida; Masami Ohtsuka; Haruko Kawato; Ken ichi Yoshida; Yoshihiro Yokomizo; Shigeru Hosono; Toshiharu Ohta; Kazuki Hoshino; Hiroko Ishida; Kumi Yoshida; Thomas E Renau; Roger Léger; Jason Z Zhang; Ving J Lee; William J Watkins
Journal:  Bioorg Med Chem Lett       Date:  2003-12-01       Impact factor: 2.823

2.  MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents.

Authors:  Ken-ichi Yoshida; Kiyoshi Nakayama; Yoshihiro Yokomizo; Masami Ohtsuka; Makoto Takemura; Kazuki Hoshino; Hiroko Kanda; Kenji Namba; Hironobu Nitanai; Jason Z Zhang; Ving J Lee; William J Watkins
Journal:  Bioorg Med Chem       Date:  2006-09-18       Impact factor: 3.641

Review 3.  Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

Authors:  Olga Lomovskaya; Keith A Bostian
Journal:  Biochem Pharmacol       Date:  2006-01-19       Impact factor: 5.858

4.  Inactivation of efflux pumps abolishes bacterial biofilm formation.

Authors:  Malin Kvist; Viktoria Hancock; Per Klemm
Journal:  Appl Environ Microbiol       Date:  2008-10-03       Impact factor: 4.792

Review 5.  Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update.

Authors:  Jessica M A Blair; Laura J V Piddock
Journal:  Curr Opin Microbiol       Date:  2009-08-05       Impact factor: 7.934

6.  Conformation of the AcrB multidrug efflux pump in mutants of the putative proton relay pathway.

Authors:  Chih-Chia Su; Ming Li; Ruoyu Gu; Yumiko Takatsuka; Gerry McDermott; Hiroshi Nikaido; Edward W Yu
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

7.  Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa.

Authors:  Thomas E Renau; Roger Léger; Rose Yen; Miles W She; Eric M Flamme; Joan Sangalang; Carla L Gannon; Suzanne Chamberland; Olga Lomovskaya; Ving J Lee
Journal:  Bioorg Med Chem Lett       Date:  2002-03-11       Impact factor: 2.823

8.  Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.

Authors:  Yoichi Hirakata; Akira Kondo; Kazuki Hoshino; Hisakazu Yano; Kazuaki Arai; Ayako Hirotani; Hiroyuki Kunishima; Natsuo Yamamoto; Masumitsu Hatta; Miho Kitagawa; Shigeru Kohno; Mitsuo Kaku
Journal:  Int J Antimicrob Agents       Date:  2009-07-16       Impact factor: 5.283

9.  Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa.

Authors:  Thomas E Renau; Roger Léger; Lubov Filonova; Eric M Flamme; Michael Wang; Rose Yen; Deidre Madsen; David Griffith; Suzanne Chamberland; Michael N Dudley; Ving J Lee; Olga Lomovskaya; William J Watkins; Toshiharu Ohta; Kiyoshi Nakayama; Yohei Ishida
Journal:  Bioorg Med Chem Lett       Date:  2003-08-18       Impact factor: 2.823

10.  Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.

Authors:  Attilio V Vargiu; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-21       Impact factor: 11.205

View more
  12 in total

1.  Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane.

Authors:  Shane M Hickey; Trent D Ashton; Gareth Boer; Christie A Bader; Michael Thomas; Alysha G Elliott; Carsten Schmuck; Heidi Y Yu; Jian Li; Roger L Nation; Matthew A Cooper; Sally E Plush; Douglas A Brooks; Frederick M Pfeffer
Journal:  Eur J Med Chem       Date:  2018-10-03       Impact factor: 6.514

2.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

3.  Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides.

Authors:  Napoleon D'Cunha; Mohammad Moniruzzaman; Keith Haynes; Giuliano Malloci; Connor J Cooper; Enrico Margiotta; Attilio V Vargiu; Muhammad R Uddin; Inga V Leus; Feng Cao; Jerry M Parks; Valentin V Rybenkov; Paolo Ruggerone; Helen I Zgurskaya; John K Walker
Journal:  ACS Infect Dis       Date:  2021-08-11       Impact factor: 5.578

4.  5-Arylideneimidazolones with Amine at Position 3 as Potential Antibiotic Adjuvants against Multidrug Resistant Bacteria.

Authors:  Aneta Kaczor; Karolina Witek; Sabina Podlewska; Joanna Czekajewska; Annamaria Lubelska; Ewa Żesławska; Wojciech Nitek; Gniewomir Latacz; Sandrine Alibert; Jean-Marie Pagès; Elżbieta Karczewska; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik
Journal:  Molecules       Date:  2019-01-26       Impact factor: 4.411

5.  Phylogenetic and functional characterisation of the Haemophilus influenzae multidrug efflux pump AcrB.

Authors:  Martijn Zwama; Akihito Yamaguchi; Kunihiko Nishino
Journal:  Commun Biol       Date:  2019-09-13

6.  Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.

Authors:  Coline Plé; Heng-Keat Tam; Anais Vieira Da Cruz; Nina Compagne; Juan-Carlos Jiménez-Castellanos; Reinke T Müller; Elizabeth Pradel; Wuen Ee Foong; Giuliano Malloci; Alexia Ballée; Moritz A Kirchner; Parisa Moshfegh; Adrien Herledan; Andrea Herrmann; Benoit Deprez; Nicolas Willand; Attilio Vittorio Vargiu; Klaas M Pos; Marion Flipo; Ruben C Hartkoorn
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

7.  Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains.

Authors:  Cristina Rodrigues Dos Santos Barbosa; Jackelyne Roberta Scherf; Thiago Sampaio de Freitas; Irwin Rose Alencar de Menezes; Raimundo Luiz Silva Pereira; Joycy Francely Sampaio Dos Santos; Sarah Silva Patrício de Jesus; Thais Pereira Lopes; Zildene de Sousa Silveira; Cícera Datiane de Morais Oliveira-Tintino; José Pinto Siqueira Júnior; Henrique Douglas Melo Coutinho; Saulo Relison Tintino; Francisco Assis Bezerra da Cunha
Journal:  J Bioenerg Biomembr       Date:  2021-06-22       Impact factor: 2.945

8.  Xanthones Active against Multidrug Resistance and Virulence Mechanisms of Bacteria.

Authors:  Fernando Durães; Diana I S P Resende; Andreia Palmeira; Nikoletta Szemerédi; Madalena M M Pinto; Gabriella Spengler; Emília Sousa
Journal:  Antibiotics (Basel)       Date:  2021-05-19

9.  Antimicrobial Activity of a Library of Thioxanthones and Their Potential as Efflux Pump Inhibitors.

Authors:  Fernando Durães; Andreia Palmeira; Bárbara Cruz; Joana Freitas-Silva; Nikoletta Szemerédi; Luís Gales; Paulo Martins da Costa; Fernando Remião; Renata Silva; Madalena Pinto; Gabriella Spengler; Emília Sousa
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-15

10.  Size-Dependent Inhibitory Effects of Antibiotic Drug Nanocarriers against Pseudomonas aeruginosa.

Authors:  Feng Ding; Preeyaporn Songkiatisak; Pavan Kumar Cherukuri; Tao Huang; Xiao-Hong Nancy Xu
Journal:  ACS Omega       Date:  2018-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.